| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |